Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up to 40% of weight loss from semaglutide ...

Chloe Stirling recalled being diagnosed with an aggressive form of stomach cancer at the age of 28 in a recent TikTok video.

Medications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in weight loss. These medications belong to a class of drugs known as GLP-1 ...

Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...

Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.Ozempic is a social media darling — with celebrities singing its praises ...

WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

Wegovy has taken the weight loss world by storm—and it's not just hype. People are finally seeing real results, and it’s changing the game for those who’ve struggled with weight for years. Unlike ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...